Popular Articles From: Former Cerner Executive Joins Streamline Health® As Executive Vice President And Chief Operating Officer to TESARO Announces Submission of Rolapitant New Drug Application (NDA) to U.S. Food and Drug Administration


David Sides To Oversee Operations, Solutions Development and Client Services ATLANTA , Sept.
Sign-up for Former Cerner Executive Joins Streamline Health® As Executive Vice President And Chief Operating Officer investment picks
2014/9/9
ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. Announces Completion of Common Stock Offering investment picks
2014/9/9
The Securities Arbitration Law Firm of Klayman & Toskes, P.A. (“K&T”), www.nasd-law.com , announced today that it is investigating the sales practices of Citigroup in connection with their sales of the CSO Fund.
Sign-up for Investor Alert: Notice From the Securities Arbitration Law Firm of Klayman & Toskes to Citigroup Customers Who Purchased Corporate Special Opportunities ("CSO") Fund investment picks
2014/9/9
The Deutsche closed-end funds listed below announced today their regular monthly distributions.
Sign-up for Certain Deutsche Closed-End Funds Declare Monthly Distributions investment picks
Fluor Corporation (NYSE: FLR) announced today that its 95 Express Lanes project yesterday received the American Road & Transportation Builders Association’s (ARTBA) Transportation Development Foundation 2014 Contractor Safety Award.
Sign-up for Fluor I-95 Transportation Project Recognized by American Road & Transportation Builders Association for Outstanding Construction Safety investment picks
2014/9/9
ComEd is increasing its staffing and opening its Emergency Operations Center as of 5 a.m. Wednesday, in preparation for severe weather expected to enter its service territory.
Sign-up for ComEd Prepares for Severe Weather Expected to Hit Northern Illinois investment picks
2014/9/9
ESCONDIDO, Calif.
Sign-up for 77th Common Stock Monthly Dividend Increase Declared By Realty Income investment picks
2014/9/9
http://media.marketwire.com/attachments/201302/57453_SeanieMacLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143515&ProfileId=051205&sourceType=1 HUNTINGTON, NY --
Sign-up for SeanieMac International Ltd Appoints Shane O'Driscoll as CEO, Garreth Core as COO investment picks
BEIJING , Sept.
Sign-up for Baidu Appoints Dr. Ya-Qin Zhang as President, New Business investment picks
The Domain Name System (DNS) is critical network infrastructure; without DNS the Internet can’t function.
Sign-up for Now Is the Time for Secure DNS: Infoblox Enhances Its Advanced DNS Protection Solution to Block the Widest Range of DNS Attacks investment picks
2014/9/8
Athabasca Oil Corporation Announces Board of Directors and Executive Changes, a Strategic Update and an Increased 2014 Capital Budget Canada NewsWire 2014 Capital Budget Increase Athabasca's Board of Directors' has approved an increase of $140 million to the 2014 capital budget, bringing the total to $667 million as follows:               2014 Capital Budget (1) ($ Millions) Previous Budget New Budget Change Q3 -Q4 2014 THERMAL OIL DIVISION             Hangingstone Project $227 $227 $0 $81 Hangingstone regional infrastructure and production support   58 58 0
Sign-up for Athabasca Oil Corporation Announces Board of Directors and Executive Changes, a Strategic Update and an Increased 2014 Capital Budget investment picks
WEST CHESTER, Ohio , Sept.
Sign-up for AK Steel Announces Concurrent Offerings of Common Stock and Senior Unsecured Notes investment picks
2014/9/8
Magnetek, Inc. (“Magnetek” or “the Company,” NASDAQ: MAG) today announced that, on September 5, 2014, it made a voluntary excess contribution of 250,000 shares of Magnetek common stock to its defined benefit pension plan (the “plan”). The contribution, which represents less than 5 percent of total pension plan assets, consists of newly issued Magnetek shares and is fully tax-deductible.
Sign-up for Magnetek Contributes Shares of Common Stock to Its Pension Plan investment picks
AstraZeneca (NYSE:AZN) today announced that once-weekly BYDUREON ® (exenatide extended-release for injectable suspension) Pen 2 mg, a prescription medicine, is now available in pharmacies across the United States.
Sign-up for BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies investment picks
Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PITTSBURGH , Sept.
Sign-up for Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™ investment picks
First and only generic 2% topical testosterone gel Product launched by Qualitest is now available DUBLIN , Sept.
Sign-up for Endo announces launch of Authorized Generic of FORTESTA® Gel investment picks
Event to be webcast live on TechCrunch website SAN FRANCISCO , Sept.
Sign-up for Salesforce.com Chairman and CEO Marc Benioff to Speak at TechCrunch Disrupt investment picks
Data demonstrate potent, broad spectrum activity against gram-positive and gram-negative bacteria, including resistant organisms that cause skin infections NEW YORK , Sept.
Sign-up for Dipexium Pharmaceuticals Presents Updated Locilex® Microbiology Data at 54th ICAAC Conference investment picks
2014/9/8
NEW YORK , Sept.
Sign-up for Sino-Global Shipping America, Ltd. Closes Ship Management Company Acquisition investment picks
2014/9/8
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that its multiple sclerosis pipeline, which includes a new generation of investigational treatments in early development, will be featured during the 30 th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) being held in Boston Sept.
Sign-up for Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS investment picks
CACI International Inc ( NYSE:CACI ) announced today it was awarded a prime contract, with a total value of $44 million if all options are exercised, to provide logistics and acquisition management support to the Naval Sea Systems Command’s (NAVSEA) Program Executive Office Littoral Combat Ship (PEO LCS). This 14-month (eight-month base and two three-month options) bridge contract represents continuing work for CACI and reinforces the company’s presence in its Logistics and Material Readiness market area.
Sign-up for CACI Awarded Prime Position on $44 Million Contract to Continue Support for U.S. Navy’s Littoral Combat Ships investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that George Tidmarsh, M.D., Ph.D., President and Chief Executive Officer, will provide a corporate overview at the Rodman & Renshaw 16th Annual Global Investment Conference taking place September 8-10 in New York City.
Sign-up for La Jolla Pharmaceutical Company to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual RetailInvestorConferences.com NEW YORK , Sept.
Sign-up for American Water to Webcast, Live, at RetailInvestorConferences.com September 11 investment picks
Exelis (NYSE:XLS) has announced that its board of directors has approved the distribution to its shareholders of all of the outstanding shares of Vectrus, Inc., its current Mission Systems business division, which will result in two separate publicly traded companies.
Sign-up for Exelis Board of Directors Approves Spin-off of Vectrus as Separate, Publicly Traded Company; Sets Record and Distribution Dates investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: Former Cerner Executive Joins Streamline Health® As Executive Vice President And Chief Operating Officer to TESARO Announces Submission of Rolapitant New Drug Application (NDA) to U.S. Food and Drug Administration
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent